Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Germany

Patent Ruling Blow For Yasmin

March 2008 | Industry News

Shares in German drug giant Bayer have fallen after a US district court ruled that the patent on its blockbuster oral contraceptive Yasmin (drospirenone and ethinyl estradiol) is invalid. The decision paves the way for US-based Barr Laboratories to introduce a low-cost generic version.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Fresenius Enters Generic Drug Market With APP Pharmaceuticals Acquisition

Companies / Germany Germany-based global healthcare company Fresenius SE has agreed to buy US generic intravenous (IV) drug specialist APP Pharmaceuticals in a deal worth an initial US$3.7bn.
July 2008
MRSA Spurs New Interest In Antibiotics

Industry / United States Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according to infectious...
March 2008
MRSA Spurs New Interest In Antibiotics

Industry / United States Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according to infectious...
March 2008
MRSA Spurs New Interest In Antibiotics

Industry / United States Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according to infectious...
March 2008
MRSA Spurs New Interest In Antibiotics

Industry / United States Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according to infectious...
March 2008


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS